BTAIVSCRL• 12 Months (Normalized)
BTAI vs CRL (BioXcel Therapeutics Inc. vs Charles River Laboratories International Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
CRL Performance $290.19
+65.48%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
-65.48 pts
CRL outperforming by 65.48 percentage points
BTAICRL
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI CRL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BTAI Price | BTAI Gain (%) | CRL Price | CRL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $- | $290.19 | +65.48% | - | |
| Oct 01, 2026 | $- | $286.83 | +63.57% | - | |
| Sep 30, 2026 | $- | $295.01 | +68.23% | - | |
| Sep 29, 2026 | $- | $295.96 | +68.77% | - | |
| Sep 28, 2026 | $- | $294.59 | +67.99% | - | |
| Sep 25, 2026 | $- | $292.84 | +66.99% | - | |
| Sep 24, 2026 | $0.04 | -98.66% | $- | - | |
| Sep 23, 2026 | $0.05 | -98.30% | $277.33 | +58.15% | -156.45% |
| Sep 22, 2026 | $0.04 | -98.31% | $285.11 | +62.59% | -160.90% |
| Sep 21, 2026 | $0.06 | -97.67% | $279.01 | +59.11% | -156.78% |
| Sep 18, 2026 | $0.06 | -97.80% | $278.06 | +58.57% | -156.37% |
| Sep 17, 2026 | $0.08 | -97.16% | $281.67 | +60.62% | -157.78% |
| Sep 16, 2026 | $0.07 | -97.47% | $273.41 | +55.91% | -153.38% |
| Sep 15, 2026 | $0.04 | -98.31% | $272.88 | +55.61% | -153.92% |
| Sep 14, 2026 | $0.05 | -98.29% | $273.11 | +55.74% | -154.03% |
Page 1 of 17